Decompensated cirrhosis of liver
Clinical trials for Decompensated cirrhosis of liver explained in plain language.
Never miss a new study
Get alerted when new Decompensated cirrhosis of liver trials appear
Sign up with your email to follow new studies for Decompensated cirrhosis of liver, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Two-Drug combo keep cirrhosis patients out of the hospital?
Disease control Recruiting nowResearchers are testing whether combining human albumin and enoxaparin is safe and effective for people with decompensated cirrhosis who are well enough to leave the hospital. The trial enrolls about 90 adults with severe liver scarring and recent complications. Participants rece…
Matched conditions: DECOMPENSATED CIRRHOSIS OF LIVER
Phase 2 • Sponsor: European Foundation for Study of Chronic Liver Failure • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can a blood pressure pill rescue failing kidneys in cirrhosis?
Disease control Recruiting nowThis trial tests whether droxidopa, an oral medication that raises blood pressure, can improve kidney function in people hospitalized with cirrhosis and acute kidney injury. The study will compare droxidopa to a placebo in 75 participants, measuring changes in blood pressure and …
Matched conditions: DECOMPENSATED CIRRHOSIS OF LIVER
Phase 2 • Sponsor: Giuseppe Cullaro, MD • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Could a common cholesterol drug help slow liver failure?
Disease control Recruiting nowThis pilot study tests whether adding the statin atorvastatin to a standard beta blocker can help people with decompensated cirrhosis, a severe form of liver disease. Fifty participants will receive either atorvastatin plus their usual beta blocker or a placebo plus beta blocker,…
Matched conditions: DECOMPENSATED CIRRHOSIS OF LIVER
Phase 2 • Sponsor: CAMC Health System • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Can a common gout drug shield the liver from cirrhosis complications?
Prevention Recruiting nowThis trial tests whether allopurinol, a drug usually used for gout, can prevent serious complications in people with decompensated cirrhosis, a late stage of liver disease. Researchers will give 54 adults with Child-Pugh B or C cirrhosis either allopurinol or a placebo for six mo…
Matched conditions: DECOMPENSATED CIRRHOSIS OF LIVER
Phase 4 • Sponsor: Bangladesh Medical University • Aim: Prevention
Last updated Sep 04, 2026 00:00 UTC